Human-Relevant In Vitro Solutions to Advance Neurological Research
LifeNet Health LifeSciences advances health and safety for humankind by providing research solutions that empower groundbreaking discoveries around the world. With 40 years of experience in tissue recovery and processing, the organization supports scientists in various industries, including pharmaceutical, biotech, agriscience, food safety, academia, and cosmetics.
LifeNet Health LifeSciences provides high-quality human biospecimens, primary cells, in vitro physiological systems, and cytotoxicity services to the scientific community. These resources include samples from both non-diseased control and disease-specific deceased donors, fulfilling unmet needs across multiple research disciplines. The company adheres to the highest operational and ethical standards, ensuring all samples come from fully authorized donors whose gifts were not suitable for clinical transplantation.
Research Biospecimens
- Brain, Skin, Gut, and More
- Healthy and Diseased
- Prospective Samples
Assay Services
- DMPK/ADME in vitro assays
- New Approach Methodologies (NAMs)
- TruVivo Services
Cells & Cell Models
- Human Hepatocytes and Liver NPCs
- TruVivo 2D+ Hepatic System
- 3D Thyroid Microtissues
- Alzheimer's Disease
- Parkinson's Disease
- Neurodegeneration
- Traumatic Brain Injury (TBI)
- Post-Traumatic Stress Disorder (PTSD)
- Chronic Traumatic Encephalopathy (CTE)
- Depression
- Chronic Pain
- Autism
Empowering Scientific Discovery
To maximize tissue quality, LifeNet Health's trained staff collaborates with each researcher to create a customized research tissue protocol. The company's commitment to quality and service is demonstrated through:
- Industry-leading protocols: Rigorous recovery, transport, and handling ensure tissue integrity and adherence to the highest standards
- Comprehensive donor information: Full authorization and research disclosure are provided with each sample, including medical and social history
- Warm Ischemia Time (WIT): Tissues are recovered with a WIT of 1-24 hours. Broad recovery capabilities: The company offers a wide range of donated tissue recovery options
- Expert support: Researchers have direct access to guidance from the LifeSciences team of scientists
- Global logistics: Recovery and logistics services are available 24/7, with capabilities for international shipping and short delivery times
Featured Products
Neurologic Tissue
High-quality neurologic tissue recovered using optimized preservation methods to maintain molecular and histological integrity. Ideal for studies in neurodegeneration, injury response, and comparative neuroanatomy.
Dorsal Root Ganglia (DRG)
Human DRG samples preserve native neuronal and glial structures critical for sensory pathway studies. Research applications include pain research, neuropathic disorders, and peripheral neurotoxicity testing.
Peripheral Nerves
Intact human peripheral nerve tissues provide a valuable model for exploring nerve injury, regeneration, and myelination. Supports translational research in neuropathies and peripheral nervous system disorders.
Cerebrospinal Fluid (CSF)
Well-characterized, donor-matched CSF enables analysis of central nervous system biomarkers and disease progression. Suitable for proteomic, metabolomic, and diagnostic development studies.
Meet Our Team
Bud Brame
General Manager, Biospecimen Research
Bud Brame brings more than 40 years of dedicated leadership to LifeNet Health, making him one of the longest-serving team members in the organization’s history. As General Manager of Biospecimens at LifeNet Health LifeSciences, Bud oversees the strategic development and operational oversight of the organization’s biospecimen research franchise, supporting the supply of high-quality human tissues, cells, and optimized media to enable medical research, drug discovery, and safety testing.
Over the course of his tenure, Bud has held key leadership roles including Vice-President of Musculoskeletal/CV Production and Vice-President/General Manager of the Skin and Wound Allograft Institute, and Vice President of Corporate Reimbursement. He played a pivotal role in launching new programs, expanding biospecimen capabilities, and guiding the organization through periods of strategic growth.
Bud is known for his commitment to process excellence, operational rigor, and mission-driven leadership. Under his guidance, LifeNet Health’s biospecimen franchise has participated in high-impact research collaborations, including programs to recover biospecimens supporting studies of traumatic brain injury and neurodegenerative disease.
.png?width=250&height=250&name=Bud%20Brame%20(2).png "Bud Brame (2)")
Jeff Thomas
Program Director, LifeSciences Biospecimens
Jeff Thomas is a leader in the life sciences industry with over 30 years of experience supporting the design and development of human organ and tissue transplantation and research biospecimen collection programs that supported product development and pre-clinical drug discovery and safety. Jeff has successfully developed efficient internal teams and external institutional partnerships to garner funding resources and create standardized methods to obtain donated human tissue from both living and deceased donors that support both transplant and large-scale scientific studies. Jeff’s experiences include strategic partnership development with hospitals, non-profit organizations, for profit corporations, national institutes of health, DOD, and other independently funded research programs.
Jeff’s career supporting both transplant and research donation has yielded numerous successful projects and programs that serve donor family services. He has managed multiple large scale ethical, legal, social implications studies for both transplant and research donation and has authored several papers and standards documents related to donor authorization practices.
.png?width=250&height=250&name=Jeff%20Thomas%20(1).png "Jeff Thomas (1)")